Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial
Titel:
Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial
Auteur:
Oki, Yasuhiro Ewer, Michael S. Lenihan, Daniel J. Fisch, Michael J. Hagemeister, Fredrick B. Fanale, Michelle Romaguera, Jorge Pro, Barbara Fowler, Nathan Younes, Anas Astrow, Alan B. Huang, Xuelin Kwak, Larry W. Samaniego, Felipe McLaughlin, Peter Neelapu, Sattva S. Wang, Michael Fayad, Luis E. Durand, Jean-Bernard Alma Rodriguez, M.